Shenzhen Capital Group Co., Ltd. (深圳市创新投资集团有限公司, known as SCGC) is one of China's largest and oldest state-backed venture capital firms. Founded in 1999 by the Shenzhen municipal government, SCGC was established to channel public capital into early-stage technology companies at a time when China's private VC market was still nascent. Its founding mandate was to support the transformation of the Pearl River Delta from low-cost manufacturing into a hub for high-technology industries.
SCGC operates under the supervision of the Shenzhen State-owned Assets Supervision and Administration Commission (SASAC), which makes it structurally different from purely private VC funds. As of publicly available filings, the firm manages assets estimated at over 100 billion RMB (approximately $14 billion USD) across direct investments and fund-of-funds vehicles – though the firm does not routinely publish detailed AUM figures. It has backed more than 1,000 portfolio companies over its lifetime and has shepherded dozens of them to IPO listings on A-share markets, the Hong Kong Stock Exchange, and Nasdaq. SCGC is headquartered in Shenzhen's Futian district and maintains offices across major Chinese technology hubs including Beijing, Shanghai, and Chengdu.
The firm's primary sectoral focus is technology, media, and telecommunications (TMT), advanced manufacturing, healthcare and biotech, clean energy, and new materials. This broad mandate reflects its role as a policy tool as much as a profit-seeking investor. Geographic focus is predominantly mainland China, with select exposure to cross-border technology deals in Southeast Asia and occasional co-investments in Israeli or European deep-tech companies alongside Chinese strategic partners.
Notable investments
SCGC's portfolio includes some of China's most prominent technology companies across multiple sectors:
- DJI – the world's leading consumer and commercial drone manufacturer, headquartered in Shenzhen. SCGC was among early institutional backers.
- BGI Genomics – one of the world's largest genomic sequencing companies. SCGC supported BGI's expansion and its eventual A-share listing.
- Meituan – China's dominant food delivery and local services platform, now listed on the Hong Kong Stock Exchange (HKEX: 3690).
- Ping An Insurance (early-stage) – SCGC holds historical stakes in several Ping An subsidiaries related to fintech.
- Inovance Technology – a leading industrial automation and robotics company listed on the Shenzhen Stock Exchange.
SCGC's disclosed blockchain and digital asset portfolio is limited. With only five recorded crypto or blockchain-related investments in public databases, the firm appears to treat this sector as a minor allocation rather than a strategic focus. Specific names of SCGC's blockchain portfolio companies are not consistently disclosed in public sources, and individual deal sizes have not been published.
Team
SCGC is led by a management committee drawn largely from government finance and state enterprise backgrounds rather than from the private technology industry. Public information about individual managing partners is limited. The firm's leadership has historically rotated in line with Shenzhen municipal government appointments. As of available records, Wang Zhengyi has served as a senior executive, but detailed biographies for current managing partners are not consistently disclosed in English-language sources. For authoritative team information, SCGC's official Chinese-language site (szvc.com.cn) and filings with the China Securities Regulatory Commission (CSRC) are the primary sources.
Recent activity
Over 2023–2025, SCGC accelerated commitments to semiconductor and advanced chip design companies, reflecting Chinese national policy to reduce reliance on foreign chip suppliers. The firm co-led or participated in several RMB-denominated funds targeting domestic chip startups in the context of US export controls. SCGC also expanded its fund-of-funds activity, deploying capital into regional government-backed VC vehicles across Guangdong province as part of China's "patient capital" policy push.
The firm remained cautious on crypto assets – a stance consistent with China's regulatory environment, where cryptocurrency trading and exchanges have been banned since 2021. Any blockchain-related activity has been confined to enterprise blockchain, supply chain traceability, and digital yuan (e-CNY) adjacent infrastructure, all of which carry explicit policy backing from Beijing.
SCGC occupies a unique position in China's venture landscape: it is large enough to move markets in domestic sectors, yet constrained by its state mandate from making the kind of high-risk, globally-oriented bets that characterize top-tier private VC firms. For investors tracking Chinese venture capital, SCGC's portfolio decisions function partly as a signal of state industrial policy. Its limited crypto exposure mirrors the broader posture of China's institutional capital toward decentralized digital assets – cautious, compliance-first, and oriented toward permissioned blockchain applications rather than public chains. Further details on SCGC can be found via Crunchbase and the